540 related articles for article (PubMed ID: 9214605)
1. Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18.
Bello D; Webber MM; Kleinman HK; Wartinger DD; Rhim JS
Carcinogenesis; 1997 Jun; 18(6):1215-23. PubMed ID: 9214605
[TBL] [Abstract][Full Text] [Related]
2. Acinar differentiation by non-malignant immortalized human prostatic epithelial cells and its loss by malignant cells.
Webber MM; Bello D; Kleinman HK; Hoffman MP
Carcinogenesis; 1997 Jun; 18(6):1225-31. PubMed ID: 9214606
[TBL] [Abstract][Full Text] [Related]
3. Prostate specific antigen and androgen receptor induction and characterization of an immortalized adult human prostatic epithelial cell line.
Webber MM; Bello D; Kleinman HK; Wartinger DD; Williams DE; Rhim JS
Carcinogenesis; 1996 Aug; 17(8):1641-6. PubMed ID: 8761420
[TBL] [Abstract][Full Text] [Related]
4. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part I. Cell markers and immortalized nontumorigenic cell lines.
Webber MM; Bello D; Quader S
Prostate; 1996 Dec; 29(6):386-94. PubMed ID: 8977636
[TBL] [Abstract][Full Text] [Related]
5. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications Part 2. Tumorigenic cell lines.
Webber MM; Bello D; Quader S
Prostate; 1997 Jan; 30(1):58-64. PubMed ID: 9018337
[TBL] [Abstract][Full Text] [Related]
6. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
Gao J; Arnold JT; Isaacs JT
Cancer Res; 2001 Jul; 61(13):5038-44. PubMed ID: 11431338
[TBL] [Abstract][Full Text] [Related]
7. Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression.
Webber MM; Quader ST; Kleinman HK; Bello-DeOcampo D; Storto PD; Bice G; DeMendonca-Calaca W; Williams DE
Prostate; 2001 Apr; 47(1):1-13. PubMed ID: 11304724
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the chemopreventive potential of retinoids using a novel in vitro human prostate carcinogenesis model.
Quader ST; Bello-DeOcampo D; Williams DE; Kleinman HK; Webber MM
Mutat Res; 2001 Sep; 496(1-2):153-61. PubMed ID: 11551491
[TBL] [Abstract][Full Text] [Related]
9. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
Bonkhoff H; Remberger K
Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398
[TBL] [Abstract][Full Text] [Related]
10. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
[TBL] [Abstract][Full Text] [Related]
11. Generation of active TGF-beta by prostatic cell cocultures using novel basal and luminal prostatic epithelial cell lines.
Salm SN; Koikawa Y; Ogilvie V; Tsujimura A; Coetzee S; Moscatelli D; Moore E; Lepor H; Shapiro E; Sun TT; Wilson EL
J Cell Physiol; 2000 Jul; 184(1):70-9. PubMed ID: 10825235
[TBL] [Abstract][Full Text] [Related]
12. Androgen induces differentiation of a human papillomavirus 16 E6/E7 immortalized prostate epithelial cell line.
Ling MT; Chan KW; Choo CK
J Endocrinol; 2001 Jul; 170(1):287-96. PubMed ID: 11431162
[TBL] [Abstract][Full Text] [Related]
13. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part 3. Oncogenes, suppressor genes, and applications.
Webber MM; Bello D; Quader S
Prostate; 1997 Feb; 30(2):136-42. PubMed ID: 9051152
[TBL] [Abstract][Full Text] [Related]
14. Nonmalignant AR-positive prostate epithelial cells and cancer cells respond differently to androgen.
Kukkonen K; Autio-Kimura B; Rauhala H; Kesseli J; Nykter M; Latonen L; Visakorpi T
Endocr Relat Cancer; 2022 Dec; 29(12):717-733. PubMed ID: 36219867
[TBL] [Abstract][Full Text] [Related]
15. Acquisition of androgen independence by human prostate epithelial cells during arsenic-induced malignant transformation.
Benbrahim-Tallaa L; Webber MM; Waalkes MP
Environ Health Perspect; 2005 Sep; 113(9):1134-9. PubMed ID: 16140617
[TBL] [Abstract][Full Text] [Related]
16. Stem/progenitor and intermediate cell types and the origin of human prostate cancer.
Tokar EJ; Ancrile BB; Cunha GR; Webber MM
Differentiation; 2005 Dec; 73(9-10):463-73. PubMed ID: 16351690
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 and epidermal growth factor promote anchorage-independent growth of immortalized human prostatic epithelial cells treated with N-methyl-N-nitrosourea.
Okamoto M; Webber MM; Quader S; Oyasu R
Prostate; 1998 Jun; 35(4):255-62. PubMed ID: 9609548
[TBL] [Abstract][Full Text] [Related]
18. A novel neoplastic primary tumor-derived human prostate epithelial cell line.
Ko D; Gu Y; Yasunaga Y; Nakamura K; Srivastava S; Moul JW; Sesterhenn IA; McLeod DG; Arnstein P; Taylor DO; Hukku B; Rhim JS
Int J Oncol; 2003 Jun; 22(6):1311-7. PubMed ID: 12738999
[TBL] [Abstract][Full Text] [Related]
19. The role of alpha 6 beta 1 integrin and EGF in normal and malignant acinar morphogenesis of human prostatic epithelial cells.
Bello-DeOcampo D; Kleinman HK; Webber MM
Mutat Res; 2001 Sep; 480-481():209-17. PubMed ID: 11506815
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
Song K; Cornelius SC; Danielpour D
Cancer Res; 2003 Aug; 63(15):4358-67. PubMed ID: 12907605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
